In the October issue of Mayo Clinic Proceedings*, analyzed a group of Mayo Clinic physicians and bioethicists, whether these genetic tests cause patients experiencing excessive worry about diseases developing. 'We have evidence of an increased concern about disease alone saw based on genetic risk factors, and then, the concern the concern 'changes in health out habits, says co-author Clayton Cowl, a specialist in preventive, occupational and aerospace medicine and a physician at the Mayo Clinic Executive Health Program.
Were.. The randomized study patients increased tendency moderate one week after genetic testing concerns, and that people worry more about unknown diseases, such as the thyroid condition Graves' disease, as is well known, such as diabetes. A year later, however, were patients who test was subjected to no more than those who do not had emphasized. Was a surprising finding that men whose genetic risk for prostate cancer was found to be lower than the of the general population and had normal laboratory and physical screening results for the disease much less stressed about the disease than the control group.Joy Melnikov, MPH of the University of California, Davis and her team are interview 255 women with significant risk factors for breast. Which interview included an evidence-based training policy meeting of of the risks and advantages of tamoxifen and the follow-up review of its knowledge of the drug and its decision to to adopt tamoxifen and non.
Products: Preferences by women evaluating risks from tamoxifen. POWER POWER) Study of for to tamoxifen for Breast Cancer Risk Reduction, Joy Melnikov, Deborah Paterniti, Rahman Azari, Christina Kuenneth, Stephen Birch, Miriam Kuppermann, James Nuovo, Janet Keyzer Stuart Hendersonville, first published online: April 11, 2005 Print Issue Date: May 15. John Wiley & Sons.